Drug Manufacturers - Specialty & Generic stocks
40 Drug Manufacturers - Specialty & Generic companies have a page on Investingly, worth $326.3B together. The largest is Takeda Pharmaceutical Co Ltd ADR (TAK) at $59.3B.
The median company trades at 23.0 times earnings, keeps 9.3% of revenue as operating profit and grew revenue 9.9% over the last year.
Cronos grew revenue fastest (+58%); United Therapeutics has the widest operating margin (44%); 7 of them pay a dividend (median yield 2.6%).
Drug Manufacturers - Specialty & Generic companies, largest first
| # | Company | Market cap | P/E | P/FCF | Revenue growth | Operating margin | ROE | Dividend yield |
|---|---|---|---|---|---|---|---|---|
| 1 | Takeda Pharmaceutical Co Ltd ADRTAK | $59.3B | 49.4x | 0.08x | +7.5% | 7.5% | 1.6% | — |
| 2 | Teva Pharma Industries Ltd ADRTEVA | $45.0B | 28.8x | 39.2x | -0.8% | 9.3% | 9.1% | — |
| 3 | Haleon plcHLN | $42.1B | 19.4x | 21.4x | -1.8% | 21.9% | 10.2% | — |
| 4 | Zoetis IncZTS | $33.3B | 13.0x | 14.6x | -0.2% | — | 83.1% | — |
| 5 | United Therapeutics CorporationUTHR | $22.8B | 19.8x | 21.9x | -1.9% | 44.4% | 20.5% | — |
| 6 | Viatris IncVTRS | $19.0B | — | 9.79x | +5.0% | -0.59% | — | — |
| 7 | Neurocrine Biosciences IncNBIX | $14.0B | 21.4x | 18.6x | +39.5% | 23.6% | 19.1% | — |
| 8 | Dr. Reddy’s Laboratories Ltd ADRRDY | $10.9B | 25.2x | 0.34x | +16.6% | 22.1% | 17.0% | — |
| 9 | Elanco Animal HealthELAN | $10.4B | — | 36.6x | +10.2% | — | -3.0% | — |
| 10 | Hims Hers Health IncHIMS | $6.8B | 73.2x | 92.4x | +38.2% | -6.0% | -43.8% | — |
| 11 | Alkermes PlcALKS | $6.5B | 43.5x | 13.6x | +27.0% | 7.0% | 3.7% | — |
| 12 | Lantheus Holdings IncLNTH | $6.3B | 23.0x | 17.7x | +2.7% | 19.4% | 21.0% | — |
| 13 | Amneal Pharmaceuticals, Inc. Class A Common StockAMRX | $6.1B | 51.8x | 22.7x | +9.9% | 14.6% | 476.5% | — |
| 14 | Kiniksa Pharmaceuticals LtdKNSA | $5.6B | 80.5x | 221.8x | +55.5% | 12.4% | 12.1% | — |
| 15 | Indivior PLC Ordinary SharesINDV | $4.1B | 17.9x | — | +13.6% | 31.6% | — | — |
| 16 | Regencell Bioscience Holdings LtdRGC | $3.7B | — | — | — | — | -87.7% | — |
| 17 | Amylyx Pharmaceuticals IncAMLX | $2.8B | — | — | — | — | -63.6% | — |
| 18 | Liquidia Technologies IncLQDA | $2.6B | 172.7x | — | +1842.7% | 37.4% | 71.0% | — |
| 19 | Bausch Health Companies IncBHC | $2.3B | 15.4x | 2.31x | +12.7% | 8.1% | — | — |
| 20 | HUTCHMED DRCHCM | $2.3B | 27.1x | — | -13.0% | -7.1% | 158.6% | — |
| 21 | Perrigo Company PLCPRGO | $2.1B | — | 14.7x | -3.2% | -37.7% | -69.0% | 7.8% |
| 22 | Prestige Brand Holdings IncPBH | $2.1B | 11.4x | 8.32x | +6.5% | 26.3% | 9.0% | — |
| 23 | BioCryst Pharmaceuticals IncBCRX | $2.0B | 6.52x | 6.10x | +33.6% | -33.3% | — | — |
| 24 | Xeris Pharmaceuticals IncXERS | $1.8B | 145.1x | 62.8x | +28.7% | 10.9% | — | — |
| 25 | AlvotechALVO | $1.6B | 57.8x | — | +19.7% | 13.3% | — | — |
| 26 | ANI Pharmaceuticals IncANIP | $1.6B | 18.2x | 9.46x | +25.9% | 15.4% | 18.1% | — |
| 27 | Phibro Animal Health CorporationPAHC | $1.5B | 15.8x | 35.6x | +4.8% | 12.8% | 25.9% | 1.3% |
| 28 | Pacira BioSciences, Inc.PCRX | $1.5B | 284.6x | 10.7x | +6.2% | 2.7% | 2.2% | — |
| 29 | Cronos Group IncCRON | $1.2B | 0.00x | 7669.1x | +58.4% | -1.4% | 6.5% | — |
| 30 | Harrow Health IncHROW | $1.1B | — | 26.3x | +10.8% | -1.0% | -244.9% | — |
| 31 | Amphastar PAMPH | $1.1B | 14.8x | 8.92x | +5.4% | 15.7% | 10.2% | — |
| 32 | Collegium Pharmaceutical IncCOLL | $712M | 17.8x | 2.17x | +6.3% | 19.5% | 15.4% | — |
| 33 | Aquestive Therapeutics IncAQST | $605M | — | — | +38.1% | -97.5% | — | — |
| 34 | Canopy Growth CorpCGC | $354M | — | — | +12.5% | -54.9% | -33.8% | — |
| 35 | Aurora Cannabis IncACB | $276M | — | — | — | — | 0.28% | — |
| 36 | Anika Therapeutics IncANIK | $263M | — | 60.3x | +15.6% | -4.2% | -2.8% | — |
| 37 | BioAge Labs, IncBIOA | $260M | — | — | +1.6% | -1026.3% | -25.2% | — |
| 38 | Akebia TherAKBA | $193M | — | 2.84x | -21.4% | -6.9% | -118.6% | — |
| 39 | Cardiol Therapeutics Inc Class ACRDL | $138M | — | — | — | — | -189.2% | — |
| 40 | Cumberland Pharmaceuticals IncCPIX | $119M | — | 24.6x | -98.5% | -30.8% | -62.6% | — |
Medians use companies with a value for that measure; P/E only counts companies with positive earnings. Every company links to its page with the reverse DCF, insider buying and 13F holders.
Other Healthcare industries
Questions
What are the largest Drug Manufacturers - Specialty & Generic stocks?
By market value: Takeda Pharmaceutical Co Ltd ADR (TAK), Teva Pharma Industries Ltd ADR (TEVA), Haleon (HLN), Zoetis (ZTS), United Therapeutics (UTHR).
What is the average P/E ratio of Drug Manufacturers - Specialty & Generic stocks?
The median Drug Manufacturers - Specialty & Generic company on Investingly trades at 23.0 times trailing earnings (companies with positive earnings only).
How many Drug Manufacturers - Specialty & Generic stocks pay a dividend?
7 of 40, with a median yield of 2.6%.
Prices and ratios as of Oct 11, 2026. Statements from SEC filings. Information only, not investment advice.